Oral indomethacin modifies small intestine biofilms and host-microbe interaction mediators
Life Sciences · 2026
DOI: 10.1016/j.lfs.2025.124114 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Sciences, 2026. Verfasst von Arezoo Haghighi und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary; Center for Pharmacology and Drug Research & Development, Se…. Hauptthemen laut MEDLINE: Indomethacin, Biofilms, Intestine, Small, Anti-Inflammatory Agents, Non-Steroidal. Die Arbeit nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nemzeti Kutatási Fejlesztési és Innovációs Hivatal, Semmelweis University, National Research Development and Innovation Office.
Abstract (Originalsprache)
BACKGROUND AND AIMS: Nonsteroidal anti-inflammatory drugs (NSAIDs) can cause small intestinal injury and dysbiosis. Although NSAID-induced dysbiosis is well-characterized and contributes to enteropathy, the changes in host-bacterial interactions during enteropathy remain largely unexplored. Here we assessed the expression pattern of six toll-like receptors (TLRs) and three antimicrobial peptides (AMPs) over the course of indomethacin (IND)-induced enteropathy in rats, and evaluated their correlations with inflammation and dysbiosis. In addition, we assessed for the first time the effect of IND on small intestinal mucosal biofilm structure. MATERIALS AND METHODS: Mucosal injury, inflammation and expression of TLR and AMP genes were evaluated at five time points following IND administration. Gut microbiota composition was determined by 16S rRNA gene sequencing. Small intestinal mucosal biofilms were visualized using fluorescent in situ hybridisation. KEY FINDINGS: We found that TLR1, TLR2 and cathelicidin were upregulated, TLR5 was downregulated, whereas TLR6 and TLR9 were not altered in enteropathy. TLR4 expression showed only subtle differences, but correlated with α-defensin 5 and β-defensin 2 levels. We found several correlations between TLRs, AMPs, inflammation and gut bacteria in severe enteropathy, but in early disease stage TLR1, TLR2, TLR5 and cathelicidin expression were more strongly associated with inflammation, whereas TLR4 and defensins were more dependent on gut dysbiosis. IND treatment also caused mild damage to the mucosal microbiota biofilm. SIGNIFICANCE: This is the first comprehensive characterization of the time-dependent changes in TLRs, AMPs and mucosal biofilm in NSAID-treated rats, which may help to identify new strategies for the treatment of enteropathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary; Center for Pharmacology and Drug Research & Development, Semmelweis University, Budapest, Hungary.
- Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary; Pharmacological and Drug Safety Research, Gedeon Richter Plc, Budapest, Hungary.
- Institute of Translational Medicine, Semmelweis University, Budapest, Hungary.
- Toulouse University, IRSD, INSERM, INRAe, ENVT, Toulouse, France.
- Toulouse University, IRSD, INSERM, INRAe, ENVT, Toulouse, France; Department of Gastroenterology and Pancreatology, Toulouse University Hospital (CHU Toulouse), Toulouse, France.
- Center for Pharmacology and Drug Research & Development, Semmelweis University, Budapest, Hungary; Cardiometabolic and HUN-REN-SU System Pharmacology Research Group, Department of Pharmacology and Pharmacotherapy, Semme…
Förderung
- Nemzeti Kutatási Fejlesztési és Innovációs Hivatal
- Semmelweis University
- National Research Development and Innovation Office
- French National Research Agency
- Innovációs és Technológiai Minisztérium
- Institut National de la Santé et de la Recherche Médicale
- European Commission
Zitieren
APA
Haghighi, A., Tóth, A. S., Demeter, Z. O., Hutka, B., Zsidai, A., Lengyel, L., Haghighi, S., Pannier, M., Le Cosquer, G., Meunier, E. S., Ágg, B., Makra, N., Ostorházi, E., Ligeti, B., Kovács, K., Kelemen, Á., Jakab, A., Wachtl, G., Kökény, G., …, & Zádori, Z. S. (2026). Oral indomethacin modifies small intestine biofilms and host-microbe interaction mediators. Life Sciences. https://doi.org/10.1016/j.lfs.2025.124114
Vancouver
Haghighi A, Tóth AS, Demeter ZO, Hutka B, Zsidai A, Lengyel L, et al. Oral indomethacin modifies small intestine biofilms and host-microbe interaction mediators. Life Sciences. 2026. doi:10.1016/j.lfs.2025.124114
BibTeX
@article{Haghighi2026,
author = {Haghighi, Arezoo and Tóth, András S and Demeter, Zsuzsanna O and Hutka, Barbara and Zsidai, Anna and Lengyel, Lili and Haghighi, Samaneh and Pannier, Melissa and Le Cosquer, Guillaume and Meunier, Elodie S and Ágg, Bence and Makra, Nóra and Ostorházi, Eszter and Ligeti, Balázs and Kovács, Krisztián and Kelemen, Ágnes and Jakab, Anna and Wachtl, Gerda and Kökény, Gábor and Szabó, Dóra and Ferdinandy, Péter and Motta, Jean-Paul and Vergnolle, Nathalie and Gyires, Klára and Zádori, Zoltán S},
title = {Oral indomethacin modifies small intestine biofilms and host-microbe interaction mediators},
journal = {Life Sciences},
year = {2026},
doi = {10.1016/j.lfs.2025.124114}
}
EUVIMED